What is ClearPoint Neuro's total equity?

ClearPoint Neuro (CLPT) reported total equity of $18.84M in Q1 2026.

How has ClearPoint Neuro's total equity changed year-over-year?

ClearPoint Neuro's total equity decreased by 5.7% year-over-year, from $19.99M to $18.84M.

What is the long-term trend for ClearPoint Neuro's total equity?

Over 5 years (2020 to 2025), ClearPoint Neuro's total equity has grown at a 63.8% compound annual growth rate (CAGR), from $2.38M to $28.02M.

What does total equity mean?

Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.

ClearPoint Neuro CLPT Total Equity

Total Equity at other companies

AbbottABT

$52.06B+6.7%

Boston ScientificBSX

$25.86B+16.4%

IAR

Integra LifeSciencesIART

$1.04B-31.6%

Zimmer Biomet HoldingsZBH

$12.67B+2.2%

MedtronicMDT

$49.46B+3.0%

Neuropace, Inc.NPCE

$14.45M-40.4%

Other financials

Income statement

See full

Revenue$12.1M+42.9%

Gross profit$7.8M+51.1%

Operating income-$8.5M-37.6%

Net income-$9.6M-58.5%

EPS (diluted)-$0.32-45.5%

Balance sheet

See full

Cash & equivalents$36.5M+195%

Total debt$63.6M+1,750%

Total assets$93.4M+211%

Cash flow

See full

Operating cash flow-$8.0M-29.1%

CapEx$645.0K+252%

Free cash flow-$8.6M-35.5%

Valuation

See full

Market cap$538.61M+69.2%

Enterprise value$565.68M+82.9%

P/S13.3×+3.4×

Profitability

See full

Gross margin62.3%+1.1pp

Operating margin-65.2%-1.9pp

Net margin-71.6%+8.8pp

FCF margin-65.7%+269pp

Returns & leverage

See full

Return on equity-149.7%+4,074pp

Debt / equity3.4×+3.2×

Current ratio5.8×+2.3×

Where this comes from

Reported directly by ClearPoint Neuro in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The official record: ClearPoint Neuro’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about ClearPoint Neuro's total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ClearPoint Neuro's total equity?: ClearPoint Neuro (CLPT) reported total equity of $18.84M in Q1 2026.
How has ClearPoint Neuro's total equity changed year-over-year?: ClearPoint Neuro's total equity decreased by 5.7% year-over-year, from $19.99M to $18.84M.
What is the long-term trend for ClearPoint Neuro's total equity?: Over 5 years (2020 to 2025), ClearPoint Neuro's total equity has grown at a 63.8% compound annual growth rate (CAGR), from $2.38M to $28.02M.
What does total equity mean?: Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.